Status:
RECRUITING
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
Lead Sponsor:
Jørgen Bjerggaard Jensen
Collaborating Sponsors:
University of Aarhus
Novo Nordisk A/S
Conditions:
Non-muscle Invasive Bladder Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Aim: To compare the surgical method of En Bloc resection to the conventional transurethral resection of non-muscle invasive bladder cancer (NMIBC) in terms of complete removal of tumour, specimen qual...
Eligibility Criteria
Inclusion
- Demographics: all BMI, smokers and non-smokers
- Primary, papillary, non-solid bladder tumour visualised by flexible cystoscopy
- Tumour diameter measured on CT-scan ≥2cm ≤6cm at largest diameter
- Ability to fully comprehend the information provided and comply with protocol
- Signed consent form
- Patients with multiple tumours can be included if it seems feasible to resect them in one procedure
Exclusion
- Clinically suspected muscle invasive bladder cancer (invasion in to bladder muscle or extravesical extension visible on CT or solid tumour without papillary elements seen at cystoscopy)
- Tumour located in a bladder diverticulum
- Investigating physician concludes that en bloc resection is not technically possible
- Pregnancy
Key Trial Info
Start Date :
March 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT05223491
Start Date
March 17 2022
End Date
December 31 2026
Last Update
June 13 2023
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, Aalborg University Hospital
Aalborg, Denmark, 9100
2
Department of Urology, Aarhus University Hospital
Aarhus, Denmark, 8200
3
Department of Urology, Herlev Hospital
Herlev, Denmark
4
Department of Urology, Regional Hospital Gødstrup
Holstebro, Denmark, 7500